Andrew Frye is senior vice president and president, APAC, for Baxter Healthcare and is the current Chairman of the Board of Directors for APACMed.
Andrew joined Baxter in 2017 from DKSH Holdings Ltd., where he served as Global Head of Healthcare from 2015 to 2017. In that role, he oversaw a portfolio of pharmaceuticals, over-the-counter and device products across 13 countries. Previously, he served as vice president of Business Development from 2011 to 2014 for DKSH Healthcare. Earlier in his career, he held a number of commercial roles with increasing responsibility at Abbott Laboratories’ Pharmaceutical and Nutrition divisions.
Andrew received a bachelor’s degree in psychobiology from the University of Southern California and master’s degree in marketing from the Anderson School of Management at the University of California. He resides with his family in Singapore.
Elisabeth is President for Siemens Healthineers in the Asia Pacific region and is currently based in Shanghai, China.
Elisabeth joined Siemens in 1998 and held several roles with increasing responsibility spanning from procurement, strategy, manufacturing and R&D, and global CEO of the Refurbished Systems Business of Siemens Healthineers. She moved to Asia in 2013 to lead the business of Siemens Healthineers across the entire portfolio spanning from Diagnostic Imaging, Laboratory Diagnostics, and Advanced Therapies in Asia Pacific. Her mission is to provide access to care and enable healthcare providers to increase value by making medicine more precise, changing the way care is delivered, improving the patient experience, and digitalizing healthcare.
Elisabeth studied in Vienna, Nanjing, and Beijing and holds a master’s degree in Economics from the Vienna University of Economics and Business as well as a master’s degree in Sinology from the University of Vienna. She is married and has one son.
James Lim, Executive Vice President and President, Greater Asia for Becton Dickinson (BD), sits on BD’s Global Leadership Management Committee reporting to the CEO. Based in Singapore, BD’s regional headquarters, James leads the business operations in China, Japan, Taiwan, Hong Kong, Australia, and New Zealand, Korea, SEA, India and Pakistan.
James joined BD in 1994 from Seagate International. Starting as an Engineering and Facility Manager for BD Medical (Singapore), after a 3-year assignment in R&D, he became a Plant Manager in 2000. In 2003, he was promoted to the role of the Director of Operations for Asia Pacific, where he was responsible for the regional manufacturing and supply chain functions, overseeing plants operating in Singapore, Bawal, India, and Suzhou, China.
In April 2008, James was appointed as the Vice President for Central and Asia Pacific, holding responsibility for the Central Asia Business Management and support functions for the entire Asia Pacific region.
Four years later, James was appointed as President of Greater Asia and an Executive Member of the company, becoming the first Asian leader to take office in the region’s 30-year history.
A strong believer in developing and retaining the best of talents, James was conferred the Leading CEO award by the Singapore Human Resources Institute (SHRI) in 2014. The award was testimony to his championship of innovative and effective HR ideas and practices and demonstration of leadership commitment to talent development within the industry.
James received his early education in Malaysia and continued to study the National University of Singapore, where he graduated with a Mechanical Engineering degree.
Married and with two teenage sons, James tries to spend as much time as possible with them between his business travels. He is passionate about automotive and is an avid fitness enthusiast.
Art Butcher is Executive Vice President and President for Boston Scientific in the Asia Pacific region, a role he has held since February 2020. Currently based in Singapore, Art is responsible for the overseeing the continued growth of our business across Asia Pacific in line with our company values. He is a member of the Boston Scientific global executive committee.
Art has been with Boston Scientific for over 20 years. Prior to his current role, Art was President, Endoscopy with global responsibility for developing and bringing to market less invasive devices for treating gastrointestinal and pulmonary conditions. He was previously Vice President and General Manager, Endoscopy in Japan.
Art has held a variety of marketing and strategic planning management positions within the Endoscopy, Urology and Pelvic Health businesses, including Vice President of Global Marketing (Endoscopy) and Vice President of New Business Development and Strategic Planning (Urology and Women’s Health). He joined Boston Scientific in 1997 as a sales representative in the Urology business.
Art holds a BA in International Relations from the University of Pennsylvania and an MBA from Columbia University.
John Collings is President, Asia Pacific, for Stryker with responsibility for all divisions within the region. He started his career with Stryker in 2016 in the Joint Replacement division where he served in various sales and marketing leadership roles, first as General Manager of the United Kingdom and then progressing to Vice President and General Manager of Europe. He was appointed to President of Stryker Asia Pacific in 2020 after assuming leadership roles with increasingly expanded responsibilities.
John is focused on driving and developing high-performing teams across the region. Having lived and worked in seven different countries, John embraces diversity and inclusion. This lays the foundation in developing mission-driven, diverse and inclusive teams that has been key to Stryker’s success. Together with Stryker’s customers, the dynamic team delivers customer-centric and differentiated innovation that drives optimal patient outcomes.
John received a Bachelor of Biology from the University of Birmingham, and Master of Research in Neuroscience from the University of Manchester. He currently resides in Singapore with his family.
Probir has three decades of medical technology industry experience and has extensively worked across medical-surgical, interventional, clinical diagnostics, infectious diseases, ophthalmology, and nutrition domains.
Probir has been with Terumo Corporation since 2012 and is currently responsible for
overseeing its operations across Asia Pacific and India. As the Regional Leader of Asia Pacific & India, he spearheads Terumo’s investments into these emerging markets for purposeful talent and business strengthening, health system scaleup through various skill interventions, and driving the long-term strategy of Terumo in Asia Pacific.
Given his keen interest in policy shaping, Probir is actively engaged in advocacy and sits on the Board of Directors for the Asia Pacific Medical Technology Association (APACMed) and Medical Technology Association of India (MTaI).
Probir also has over a decade’s teaching experience, specifically around strategy, leadership
development, coaching and performance management. His passion towards MedTech sees him mentor start-ups and entrepreneurs.
Probir resides in Singapore and is a frequent visitor to all of the Asia Pacific markets and Japan.
Lam Chee Hong is the President and a Member of the Management Board of B. Braun Asia Pacific. As President, he is responsible for the Group’s pharmaceutical and medical technology business across the region.
Chee Hong begin his career with B. Braun in 1986 as a medical sales representative. In recognition of his leadership, versatility and business performance, he was continually entrusted with additional key responsibilities and ascended through the levels in the organisation to assume the most senior leadership role in B. Braun Asia Pacific.
Based in B. Braun’s regional headquarters in Penang, Malaysia, he also oversees B. Braun Group’s largest production sites in the world with over 7,700 employees.
Chee Hong graduated with a Bachelor of Economics from the University of Malaya. He is married and has two children.
Chris Lee is Senior Vice President and President of Medtronic, Asia Pacific (APAC) and serves as a member of the Medtronic Executive Committee. He oversees the Medtronic APAC region where the company has presence in more than 20 countries with about 10,000 employees across the region. Chris joined Medtronic in 2012 as President of the Greater China region and was named as President of APAC in December of 2017. Under his leadership, the Greater China region achieved five consecutive years of double-digit growth by bringing meaningful innovation and expanding access to more patients locally.
Chris has a strong track record of global leadership in the healthcare industry — both in pharmaceutical and medical technology. He is known for his inclusive leadership style, commitment to meritocracy, and proven business success. During his time in China, Chris developed strategic partnerships with the Chinese government and was a strong supporter of corporate social responsibility — leading the company’s effective relief efforts to respond to the Lushan earthquake in Sichuan Province.
Prior to Medtronic, Chris was Regional Head and Senior Vice President, APAC at Bayer HealthCare where he was responsible for overall operations in the region, including pharmaceuticals, consumer over-the-counter, animal health, and medical devices. Chris has also held roles of increasing responsibility in several multinational companies, including Bristol Myers Squibb and Merck Sharpe and Dohme, while based in APAC and the U.S., respectively.
Chris is a pioneer in the management of workplace happiness and is the author of two bestselling books, one on emotional management and one on marketing. He was also formerly an executive director in the pharmaceutical industry associations of China (RDPAC), Australia (Medicines Australia), and Korea (Korea Pharma).
Chris serves on the board of the Asia Pacific Medical Technology Association (APACMed).
Chris holds a bachelor’s degree from the University of Arizona, Tucson and a master’s degree from the American Graduate School of International Management (Thunderbird). He is fluent in English and Korean, with a good understanding of Mandarin Chinese and Japanese.
Lance Little became the Managing Director, Region Asia Pacific for Roche Diagnostics in 2012. Prior to that, he was the Managing Director of Roche Diagnostics India (including the Indian sub-region). His experience as Managing Director extends to both Roche Diagnostics Thailand and Roche Diagnostics New Zealand.
Lance joined Roche in New Zealand in 1995 in the technical support and management division of Boehringer Mannheim’s Clinical Chemistry portfolio, before moving on to sales and marketing roles. He was appointed Managing Director of Roche Diagnostics Thailand in 2008 before returning to New Zealand to take up the role of Managing Director in 2009.
Lance started his career as a Medical Laboratory Scientist, specialising in Biochemistry at Auckland Hospital Laboratory in New Zealand. Following that, he spent some time managing the Automation Laboratory at Diagnostic Laboratories in Auckland.
Tim Schmid is the Company Group Chairman, Johnson & Johnson Medical Devices, Asia Pacific where he leads the company’s efforts to bring market leading surgical, orthopedic and interventional solutions to patients in need across Asia.
Tim has been with Johnson & Johnson for over 25 years and has held diverse leadership positions in sales, strategic marketing and general management across multiple businesses and geographies. Most recently, he served as Chief Strategic Customer Officer, where he led a transformation of Johnson & Johnson’s business-to-business relationships with hospital systems in the US. Prior to this he was President of Johnson & Johnson’s surgery business, Ethicon, where led a major turnaround in the US. This included the integration of five standalone businesses and the implementation of a new go-to-market model to address the rapidly changing needs of both clinicians and health care administrators.
Tim is a global executive who, in addition to leading business transformations across multiple continents, builds strong teams that have a track record of customer orientated solutions, growth and leadership across the medical technology industry. He is a champion for the value of diversity, currently leading the company’s diversity and inclusion efforts across Asia Pacific. He was also instrumental in establishing Johnson & Johnsons global partnership with Operation Smile, focused on bringing safe and effective surgical care to children suffering from cleft lip or cleft palate.
Educated in South Africa, Canada and the United Kingdom, Tim has lived and worked in six countries on four continents. He earned his undergraduate degree from the University of Western Ontario in Canada, and an MBA from Richmond University in the United Kingdom.
Paul Tan is the Divisional Vice President, APAC of Abbott Vascular Division. Paul joined Abbott in 2014 as General Manager, China. He was promoted to Divisional Vice President & General Manager, Greater China in 2017 and to current role in September 2019. Prior to joining Abbott, Paul was General Manager, China for Molnlycke Health Care.
Paul has been in the healthcare industry for over 20 years and has held leadership positions in companies, including Genzyme Corporation as a Commercial Manager and Teleflex as General Manager of Greater China.
Paul holds a master’s degree in structural engineering from Tongji University and a master’s in business administration from China Europe International Business School (CEIBS).
Julie Tay is Senior Vice President and Managing Director, Asia Pacific, responsible for Align Technology’s market development and operational execution of all Align Technology products and services in the Asia Pacific region. She is also a member of the Executive Management Committee. She joined the company in March 2013 originally as Vice President and Managing Director, Asia Pacific.
Ms. Tay has more than 20 years’ experience in international management of various segments including consumer healthcare, medical devices and chemical businesses across Asia.
Prior to joining Align Technology, Ms. Tay was regional head of Bayer Healthcare (Diabetes Care) overseeing operations across Asia where she grew the business into a sustainable and profitable operation in three years. Prior to Bayer, Ms. Tay spent 15 years with Johnson & Johnson Medical where she was instrumental in establishing the LifeScan franchise within Asia.
Ms. Tay holds an M.B.A. from Curtin University of Technology (Australia) and a B.A. degree from the National University of Singapore.